GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stratec SE (OTCPK:SRBZF) » Definitions » 3-Year Revenue Growth Rate

Stratec SE (Stratec SE) 3-Year Revenue Growth Rate : 1.50% (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Stratec SE 3-Year Revenue Growth Rate?

Stratec SE's Revenue per Share for the three months ended in Mar. 2024 was $4.55.

During the past 12 months, Stratec SE's average Revenue per Share Growth Rate was -2.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was 1.50% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.30% per year. During the past 10 years, the average Revenue per Share Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Stratec SE was 23.00% per year. The lowest was 1.50% per year. And the median was 8.20% per year.


Competitive Comparison of Stratec SE's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Stratec SE's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stratec SE's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stratec SE's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Stratec SE's 3-Year Revenue Growth Rate falls into.



Stratec SE 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Stratec SE  (OTCPK:SRBZF) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Stratec SE 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Stratec SE's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Stratec SE (Stratec SE) Business Description

Traded in Other Exchanges
Address
Gewerbestrasse 37, Birkenfeld, RP, DEU, 75217
Stratec SE designs and manufactures automated analyzer systems for laboratory data management and solutions for molecular diagnostic sample preparation and stabilization. Its business segments are Instrumentation, Diatron and Smart Consumables. Its Instrumentation segment is engaged in designing and manufacturing automated analyzer systems for clinical diagnostics and biotechnology customers. The Diatron segment comprises the business with systems, system components, consumables, and tests in the low throughput hematology and clinical chemistry segment. Its Smart Consumables segment is engaged in developing and selling scientific materials, such as nucleic acid purification. The company generates maximum revenue from the Instrumentation segment.

Stratec SE (Stratec SE) Headlines

From GuruFocus